Drug recall · June 28, 2023
Glycopyrrolate Tablets recall
Why: Failed Impurities/Degradation Specifications
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Glycopyrrolate Tablets, USP, 1 mg, 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, NDC 13107-014-01
- Lots / codes
Lot #: 01421038A1, Exp. Date 05/2023
- Company
- Aurolife Pharma, LLC, Dayton, NJ
- Distribution
- Nationwide within the United States
- Initiated
- May 18, 2023
- Classified
- June 20, 2023
- Reported
- June 28, 2023
- Ended
- August 28, 2024
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Glycopyrronium
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.